[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100512627":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":279,"collaborators":10,"id":281,"slug":282,"hasResults":283,"nctId":284,"briefTitle":285,"officialTitle":286,"acronym":10,"eligibilityCriteria":287,"healthyVolunteers":283,"sex":288,"minAge":289,"maxAge":10,"enrollmentInfo":290,"targetDuration":293,"studyType":294,"phases":10,"briefSummary":295,"conditions":296,"keywords":10,"overallStatus":56,"whyStopped":10,"lastUpdateSubmitDate":298,"lastUpdatePostDateStruct":299,"startDateStruct":302,"completionDateStruct":304,"leadSponsor":306,"locationsCount":307},{"fullName":5,"class":6},"Hoffmann-La Roche","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1",null,"Unfit\u002Ffrail participants with DLBCL who are untreated before the administration of polatuzumab and who have started receiving polatuzumab at physician's discretion in accordance with local clinical practice and\u002For labeling will be observed for safety and efficacy until death, withdrawal of consent, loss to follow-up or end of study whichever occurs first (up to approximately 3 years).",[13],"Drug: Polatuzumab Vedotin",{"label":15,"type":10,"description":16,"interventionNames":17},"Cohort 2","Participants with DLBCL who can not be classified into unfit\u002Ffrail but are untreated before the administration of polatuzumab and who have started receiving polatuzumab at physician's discretion in accordance with local clinical practice and\u002For labeling will be observed for safety and efficacy until death, withdrawal of consent, loss to follow-up or end of study whichever occurs first (up to approximately 3 years).",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Cohort 3","Participants with relapsed or refractory (R\u002FR) DLBCL who have started receiving polatuzumab at physician's discretion in accordance with local clinical practice and\u002For labeling will be observed for safety and efficacy until death, withdrawal of consent, loss to follow-up or end of study whichever occurs first (up to approximately 3 years).",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"DRUG","Polatuzumab Vedotin","Polatuzumab vedotin will be administered at the discretion of the physician per local clinical practice and local labeling.",[9,15,19],[29],"POLIVY ®",[31],{"name":32,"affiliation":5,"role":33},"Clinical Trials","STUDY_DIRECTOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":10,"email":39},"ML44616 https:\u002F\u002Fforpatients.roche.com\u002F","CONTACT","888-662-6728 (U.S. Only)","global-roche-genentech-trials@gene.com",[41,54,61,67,72,80,89,94,103,112,121,129,138,147,156,162,171,180,186,195,203,212,221,227,236,245,254,263,271],{"facility":42,"status":43,"city":44,"state":10,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":10},"Peking Union Medical College Hospital","ACTIVE_NOT_RECRUITING","Beijing","100032","China","CN",{"type":49,"coordinates":50},"Point",[51,52],116.39723,39.9075,{"lat":52,"lon":51},{"facility":55,"status":56,"city":44,"state":10,"zip":57,"country":46,"countryCode":47,"cosmosGeoPoint":58,"geoPoint":60,"contacts":10},"Peking University Third Hospital","RECRUITING","100191",{"type":49,"coordinates":59},[51,52],{"lat":52,"lon":51},{"facility":62,"status":43,"city":44,"state":10,"zip":63,"country":46,"countryCode":47,"cosmosGeoPoint":64,"geoPoint":66,"contacts":10},"Beijing Hospital of Ministry of Health","100730",{"type":49,"coordinates":65},[51,52],{"lat":52,"lon":51},{"facility":68,"status":43,"city":44,"state":10,"zip":63,"country":46,"countryCode":47,"cosmosGeoPoint":69,"geoPoint":71,"contacts":10},"Beijing Tongren Hospital, Capital Medical University",{"type":49,"coordinates":70},[51,52],{"lat":52,"lon":51},{"facility":73,"status":43,"city":74,"state":10,"zip":10,"country":46,"countryCode":47,"cosmosGeoPoint":75,"geoPoint":79,"contacts":10},"The First Bethune Hospital of Jilin University","Changchun",{"type":49,"coordinates":76},[77,78],125.32278,43.88,{"lat":78,"lon":77},{"facility":81,"status":43,"city":82,"state":10,"zip":83,"country":46,"countryCode":47,"cosmosGeoPoint":84,"geoPoint":88,"contacts":10},"Xiangya Hospital of Centre-South University","Changsha","410008",{"type":49,"coordinates":85},[86,87],112.97087,28.19874,{"lat":87,"lon":86},{"facility":90,"status":56,"city":82,"state":10,"zip":10,"country":46,"countryCode":47,"cosmosGeoPoint":91,"geoPoint":93,"contacts":10},"Third Xiangya Hospital of Central South University",{"type":49,"coordinates":92},[86,87],{"lat":87,"lon":86},{"facility":95,"status":43,"city":96,"state":10,"zip":97,"country":46,"countryCode":47,"cosmosGeoPoint":98,"geoPoint":102,"contacts":10},"Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital","Chengdu","610072",{"type":49,"coordinates":99},[100,101],104.06667,30.66667,{"lat":101,"lon":100},{"facility":104,"status":43,"city":105,"state":10,"zip":106,"country":46,"countryCode":47,"cosmosGeoPoint":107,"geoPoint":111,"contacts":10},"Zhujiang Hospital, Southern Medical University","Guangzhou","510280",{"type":49,"coordinates":108},[109,110],113.25,23.11667,{"lat":110,"lon":109},{"facility":113,"status":56,"city":114,"state":10,"zip":115,"country":46,"countryCode":47,"cosmosGeoPoint":116,"geoPoint":120,"contacts":10},"Guizhou Cancer Hospital","Guiyang","550004",{"type":49,"coordinates":117},[118,119],106.71667,26.58333,{"lat":119,"lon":118},{"facility":122,"status":56,"city":123,"state":10,"zip":10,"country":46,"countryCode":47,"cosmosGeoPoint":124,"geoPoint":128,"contacts":10},"Hainan Cancer Hospital","Haikou",{"type":49,"coordinates":125},[126,127],110.34651,20.03421,{"lat":127,"lon":126},{"facility":130,"status":56,"city":131,"state":10,"zip":132,"country":46,"countryCode":47,"cosmosGeoPoint":133,"geoPoint":137,"contacts":10},"Affiliated Hospital of Inner Mongolia Medical University","Hohhot","010000",{"type":49,"coordinates":134},[135,136],111.65222,40.81056,{"lat":136,"lon":135},{"facility":139,"status":56,"city":140,"state":10,"zip":141,"country":46,"countryCode":47,"cosmosGeoPoint":142,"geoPoint":146,"contacts":10},"Jiangxi Cancer Hospital","Nanchang","330029",{"type":49,"coordinates":143},[144,145],115.85306,28.68396,{"lat":145,"lon":144},{"facility":148,"status":43,"city":149,"state":10,"zip":150,"country":46,"countryCode":47,"cosmosGeoPoint":151,"geoPoint":155,"contacts":10},"Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University)","Nanjing","210029",{"type":49,"coordinates":152},[153,154],118.77778,32.06167,{"lat":154,"lon":153},{"facility":157,"status":43,"city":149,"state":10,"zip":158,"country":46,"countryCode":47,"cosmosGeoPoint":159,"geoPoint":161,"contacts":10},"Jiangsu Cancer Hospital","211100",{"type":49,"coordinates":160},[153,154],{"lat":154,"lon":153},{"facility":163,"status":56,"city":164,"state":10,"zip":165,"country":46,"countryCode":47,"cosmosGeoPoint":166,"geoPoint":170,"contacts":10},"The Affiliated Hospital Of Qingdao University","Qingdao","DUMMY_VALUE",{"type":49,"coordinates":167},[168,169],120.38042,36.06488,{"lat":169,"lon":168},{"facility":172,"status":56,"city":173,"state":10,"zip":174,"country":46,"countryCode":47,"cosmosGeoPoint":175,"geoPoint":179,"contacts":10},"Ruijin Hospital Shanghai Jiaotong University School of Medicine","Shanghai","200025",{"type":49,"coordinates":176},[177,178],121.45806,31.22222,{"lat":178,"lon":177},{"facility":181,"status":43,"city":173,"state":10,"zip":182,"country":46,"countryCode":47,"cosmosGeoPoint":183,"geoPoint":185,"contacts":10},"Tongji Hospital of Tongji University","200065",{"type":49,"coordinates":184},[177,178],{"lat":178,"lon":177},{"facility":187,"status":56,"city":188,"state":10,"zip":189,"country":46,"countryCode":47,"cosmosGeoPoint":190,"geoPoint":194,"contacts":10},"China Medical University (CMU) First Affiliated Hospital","Shenyang","110001",{"type":49,"coordinates":191},[192,193],123.43278,41.79222,{"lat":193,"lon":192},{"facility":196,"status":43,"city":197,"state":10,"zip":10,"country":46,"countryCode":47,"cosmosGeoPoint":198,"geoPoint":202,"contacts":10},"The Fourth Hospital of Hebei Medical University","Shijiazhuang",{"type":49,"coordinates":199},[200,201],114.47861,38.04139,{"lat":201,"lon":200},{"facility":204,"status":43,"city":205,"state":10,"zip":206,"country":46,"countryCode":47,"cosmosGeoPoint":207,"geoPoint":211,"contacts":10},"Shanxi Province Cancer Hospital","Taiyuan","030013",{"type":49,"coordinates":208},[209,210],112.56028,37.86944,{"lat":210,"lon":209},{"facility":213,"status":56,"city":214,"state":10,"zip":215,"country":46,"countryCode":47,"cosmosGeoPoint":216,"geoPoint":220,"contacts":10},"Tianjin Medical University General Hospital","Tianjin","300052",{"type":49,"coordinates":217},[218,219],117.17667,39.14222,{"lat":219,"lon":218},{"facility":222,"status":56,"city":214,"state":10,"zip":223,"country":46,"countryCode":47,"cosmosGeoPoint":224,"geoPoint":226,"contacts":10},"Tianjin Cancer Hospital","300060",{"type":49,"coordinates":225},[218,219],{"lat":219,"lon":218},{"facility":228,"status":43,"city":229,"state":10,"zip":230,"country":46,"countryCode":47,"cosmosGeoPoint":231,"geoPoint":235,"contacts":10},"Xinjiang Medical University Cancer Hospital","Ürümqi","830011",{"type":49,"coordinates":232},[233,234],87.60046,43.80096,{"lat":234,"lon":233},{"facility":237,"status":43,"city":238,"state":10,"zip":239,"country":46,"countryCode":47,"cosmosGeoPoint":240,"geoPoint":244,"contacts":10},"Union Hospital Tongji Medical College Huazhong University of Science and Technology","Wuhan","430022",{"type":49,"coordinates":241},[242,243],114.26667,30.58333,{"lat":243,"lon":242},{"facility":246,"status":56,"city":247,"state":10,"zip":248,"country":46,"countryCode":47,"cosmosGeoPoint":249,"geoPoint":253,"contacts":10},"Wuxi People's Hospital","Wuxi","214023",{"type":49,"coordinates":250},[251,252],120.28857,31.56887,{"lat":252,"lon":251},{"facility":255,"status":43,"city":256,"state":10,"zip":257,"country":46,"countryCode":47,"cosmosGeoPoint":258,"geoPoint":262,"contacts":10},"First Affiliated Hospital of Medical College of Xi'an Jiaotong University","Xi'an","710061",{"type":49,"coordinates":259},[260,261],108.92861,34.25833,{"lat":261,"lon":260},{"facility":264,"status":56,"city":265,"state":10,"zip":10,"country":46,"countryCode":47,"cosmosGeoPoint":266,"geoPoint":270,"contacts":10},"The Affiliated Hospital of Xuzhou Medical University","Xuzhou",{"type":49,"coordinates":267},[268,269],117.28386,34.20442,{"lat":269,"lon":268},{"facility":272,"status":56,"city":273,"state":10,"zip":10,"country":46,"countryCode":47,"cosmosGeoPoint":274,"geoPoint":278,"contacts":10},"Henan Cancer Hospital","Zhengzhou",{"type":49,"coordinates":275},[276,277],113.64861,34.75778,{"lat":277,"lon":276},{"type":280,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100512627","a-study-to-evaluate-the-effectiveness-and-safety-of-polatuzumab-in-real-world-clinical-practice-among-adult-chinese-participants-with-diffuse-large-b-cell-lymphoma-100512627",false,"NCT05954910","A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma","The Effectiveness and Safety of Polatuzumab in Real-World Clinical Practice Among Chinese Adult Patients With Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter, Registry Study","Inclusion Criteria:\n\n* Be diagnosed as DLBCL\n* Cohort 1: diagnosed as unfit\u002Ffrail DLBCL. The unfit\u002Ffrail is defined as aged 80 years or older, or younger than 80 years but with comorbidity and not tolerant to the standardized dose of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy according to investigator's judgment\n* Cohort 2: diagnosis as DLBCL but could not be classified into unfit\u002Ffrail\n* Cohort 3: relapse or refractory to previous treatment\n\nExclusion Criteria:\n\n* Participant who currently participates in or with plan to participate in any interventional clinical trial\n* Any other reason that, in the investigator's opinion, makes the participant unsuitable to participate in this study.","ALL","18 Years",{"count":291,"type":292},1000,"ESTIMATED","3 Years","OBSERVATIONAL","The purpose of this study is to assess the progression free survival (PFS) in the real-world settings of polatuzumab among Chinese diffuse large B cell lymphoma (DLBCL) participants.",[297],"Diffuse Large B-Cell Lymphoma","2026-06-30",{"date":300,"type":301},"2026-07-01","ACTUAL",{"date":303,"type":301},"2023-08-25",{"date":305,"type":292},"2027-05-31",{"name":5,"class":6},29]